Organigram Investor Dashboard

Company Overview:

Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

[stock_market_chart symbol=”OGI.V” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]

Key Share Information:

Current Share Price#N/A
Market Capitalization (in Millions)#N/A
Last Quarter (Share Data)2/28/2019
Shares Outstanding (in Millions)139.57
Options (in Millions)4.50
Warrants (in Millions)3.45
Fully Diluted Shares (in Millions)148.72

Enterprise Value (in Millions)$6,466.90
TTM Revenue$122.12
TTM Growth Margin %28.66%
TTM Operating Expenses$173.06
TTM OCF-$207.76
P/S TTM49.03
P/S (Last Quarter Run Rate)32.61

Key Balance Sheet Information (in Millions $CAD):

 CYQ4'16
Q1'17
CYQ1'17
Q2'17
CYQ2'17
Q3'17
CYQ3'17
Q4'17
CYQ4'17
Q1'18
CYQ1'18
Q2'18
CYQ2'18
Q3'18
CYQ3'18
Q4'18
CYQ4'18
Q1'19
CYQ1'19
Q2'19
Cash$1.83$1.33$2.71$1.96$7.63$53.72$31.61$55.06$30.16$12.48
Biological Assets$1.88$2.93$2.46$2.78$2.92$4.60$9.32$19.86$26.35$19.84
Inventory$4.18$2.66$2.04$2.63$4.22$8.71$17.57$44.97$91.44$95.13
Total Assets$57.08$91.22$89.37$92.81$96.61$268.77$272.13$302.57$368.63$376.15
Net Tangible Assets$57.08$91.22$89.37$90.45$94.28$266.62$271.13$301.61$368.63
Intangibles/Goodwill$2.36$2.33$2.15$1.00$0.96$0.00
Total Liabilities$6.85$8.50$4.03$9.78$10.06$108.00$107.36$117.97$135.66$99.27

Key Operating Items (Quarterly in Millions $CAD):

 CYQ4'16
Q1'17
CYQ1'17
Q2'17
CYQ2'17
Q3'17
CYQ3'17
Q4'17
CYQ4'17
Q1'18
CYQ1'18
Q2'18
CYQ2'18
Q3'18
CYQ3'18
Q4'18
CYQ4'18
Q1'19
CYQ1'19
Q2'19
Revenue$2.23$1.45$1.92$7.74$2.69$3.22$3.71$11.94$14.48$33.47
Change in Fair Value of Biologial Assets-$0.69-$0.37-$0.58-$1.37$0.72$4.38$10.0746.0242.93-$8.09
Gross Margin$0.76-$3.98-$0.76-$3.13$1.62$6.52$12.1252.5051.75$7.96
Marketing and Sales$0.67$0.70$0.69$2.85$1.13$1.15$1.756.302.36$0.00
Investor Relations
Total Operating Expenses$1.48$1.91$1.70$8.04$3.06$4.30$5.6216.085.50$9.73
Operating Cash Flow (Quarterly)$0.88-$3.42-$2.36-$1.22-$0.08$2.16-$7.26-7.52-14.81-$7.56
Investing Cash Flow (Quarterly)-$10.81-$34.87$2.27$0.82$2.29-$119.81-$13.1332.65-24.02$40.92
Financing Cash Flow (Quarterly)$1.89$37.80$1.47-$0.35$3.47$163.73-$1.71-1.5713.92-$1.45

Listing Statement

All of the information on this dashboard was collected on a best efforts basis. This information should not be relied upon to make investment decisions. Always do your own diligence when purchasing a security and contact a licensed financial representative.

Share
Tweet
Share